Binda, K. H., Real, C. C., Simonsen, M. T., Grove, E. K., Bender, D., Gjedde, A., Brooks, D. J. & Landau, A. M. (2025). Acute transcutaneous auricular vagus nerve stimulation modulates presynaptic SV2A density in healthy rat brain: An in vivo microPET study. Psychophysiology, 62(1), Article e14709. https://doi.org/10.1111/psyp.14709

Sathyanarayana, S., Pasquini, J., Ledingham, D., Mitra, D., Warren, N. & Pavese, N. (2025). Case report -Cavernoma involving substantia nigra and nigrostriatal pathway as a rare cause of secondary parkinsonism with a 5 year follow up. Parkinsonism and Related Disorders, 132, Article 107281. https://doi.org/10.1016/j.parkreldis.2025.107281

Krogsbaek, M., Larsen, N. Y., Yarmahmoudi, F., Søndergaard, J., Landau, A. M., Sanchez, C. & Nyengaard, J. R. (2025). Chronic olanzapine treatment leads to increased opioid receptor expression and changes in feeding regulating neurons in the female rat hypothalamus. Psychoneuroendocrinology, 171, Article 107225. https://doi.org/10.1016/j.psyneuen.2024.107225

Baun, A. M., Iranzo, A., Terkelsen, M. H., Stokholm, M. G., Stær, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Borghammer, P., Tolosa, E., Eskildsen, S. F. & Pavese, N. (2025). Cuneus atrophy and Parkinsonian phenoconversion in cognitively unimpaired patients with isolated REM sleep behavior disorder. Journal of Neurology, 272(1), Article 59. https://doi.org/10.1007/s00415-024-12762-x

Sun, L., Landau, A. M., Tang, J. & Roivainen, A. (2025). Dark seasons enhance brain and brown adipose tissue interactions related to mu-opioid receptor signaling. European journal of nuclear medicine and molecular imaging. Advance online publication. https://doi.org/10.1007/s00259-025-07272-5

Pasquini, J., Sigurdsson, H. P., Firbank, M., Best, L., Foster, V., Galley, D., Maxwell, R., Silani, V., Ceravolo, R., Petrides, G., Brooks, D. J. & Pavese, N. (2025). Locus coeruleus neuromelanin, cognitive dysfunction, and brain metabolism in multiple system atrophy. Journal of Neurology, 272(3), 195. Article 195. https://doi.org/10.1007/s00415-025-12932-5

Galgani, A., Lombardo, F., Frijia, F., Scotto, M., Tognoni, G., Pavese, N. & Giorgi, F. S. (2025). Locus Coeruleus Sexual Dimorphism and Its Impact on Cognitive Impairment and Cortical Atrophy in Alzheimer's Disease. Neurodegenerative Diseases. Advance online publication. https://doi.org/10.1159/000544882

Silva, N. R., Arjmand, S., Domingos, L. B., Chaves-Filho, A. M., Mottin, M., Real, C. C., Waszkiewicz, A. L., Gobira, P. H., Ferraro, A. N., Landau, A. M., Andrade, C. H., Müller, H. K., Wegener, G. & Joca, S. R. L. (2025). Modulation of the endocannabinoid system by (S)-ketamine in an animal model of depression. Pharmacological Research, 211, 107545. Article 107545. https://doi.org/10.1016/j.phrs.2024.107545

Anzalone, M., Karam, S. A., Briting, S. R. R., Petersen, S., Thomsen, M. B., Babcock, A. A., Landau, A. M., Finsen, B. & Metaxas, A. (2025). Serotonin-2B receptor (5-HT_2BR) expression and binding in the brain of APP_swe/PS1_dE9 transgenic mice and in Alzheimer's disease brain tissue. Neuroscience Letters, 844, Article 138013. https://doi.org/10.1016/j.neulet.2024.138013

Pasquini, J., Firbank, M. J., Best, L., Foster, V., Stewart, C., Silani, V., Durcan, R., Roberts, G., Petrides, G., Ceravolo, R., Brooks, D. J., Anderson, K. N. & Pavese, N. (2025). Substantia nigra and locus coeruleus microstructural abnormalities in isolated rapid eye movement sleep behaviour disorder and Parkinson's disease. Brain Communications, 7(1), fcaf023. Article fcaf023. https://doi.org/10.1093/braincomms/fcaf023

Juul-Madsen, K., Parbo, P., Ismail, R., Ovesen, P. L., Schmidt, V., Madsen, L. S., Thyrsted, J., Gierl, S., Breum, M., Larsen, A., Andersen, M. N., Romero-Ramos, M., Holm, C. K., Andersen, G. R., Zhao, H., Schuck, P., Nygaard, J. V., Sutherland, D. S., Eskildsen, S. F. ... Vorup-Jensen, T. (2024). Amyloid-β aggregates activate peripheral monocytes in mild cognitive impairment. Nature Communications, 15(1), Article 1224. https://doi.org/10.1038/s41467-024-45627-y

Hvingelby, V., Carra, R. B., Terkelsen, M. H., Hamani, C., Capato, T., Košutzká, Z., Krauss, J. K., Moro, E., Pavese, N., Cury, R. G. & Gait Study Group (2024). A Pragmatic Review on Spinal Cord Stimulation Therapy for Parkinson's Disease Gait Related Disorders: Gaps and Controversies. Movement Disorders Clinical Practice, 11(8), 927-947. https://doi.org/10.1002/mdc3.14143

Rossi, R., Bærentzen, S. L., Thomsen, M., Real, C. C., Wegener, G., Grassi-Oliveira, R., Gjedde, A. & Landau, A. (2024). A single dose of cocaine raises SV2A density in hippocampus of adolescent rats. Acta Neuropsychiatrica, 36(2), 109-117. https://doi.org/10.1017/neu.2023.14

Bærentzen, S. L., Waszkiewicz, A. L., Thomsen, M., Knudsen, C. M. R., Elfving, B. & Landau, A. (2024). A single subanaesthetic dose of the rapid-acting antidepressant S-ketamine raises presynaptic SV2A density in limbic regions of the Wistar Kyoto rat model of depression. Neuroscience Applied, 3, Article 104079. https://doi.org/10.1016/j.nsa.2024.104079

Tuil, M. E., Calsolaro, V., Crook, H., Femminella, G. D., Pasqualetti, G., Buckley, C., Trigg, W., Gentleman, S., Brooks, D. J., Jogaudaite, S., Abarrategui, J. A., Hinz, R. & Edison, P. (2024). Basic Science and Pathogenesis. Alzheimer's & dementia : the journal of the Alzheimer's Association, 20 Suppl 1, e092255. Article e092255. https://doi.org/10.1002/alz.092255

Madsen, L. S., Kjeldsen, P. L., Ismail, R., Parbo, P., Østergaard, L., Brooks, D. J. & Eskildsen, S. F. (2024). Capillary dysfunction in healthy elderly APOE ε4 carriers with raised brain Aβ deposition. Alzheimer's & Dementia, 20(1), 459-471. https://doi.org/10.1002/alz.13461

Firbank, M. J., Pasquini, J., Best, L., Foster, V., Sigurdsson, H. P., Anderson, K. N., Petrides, G., Brooks, D. J. & Pavese, N. (2024). Cerebellum and basal ganglia connectivity in isolated REM sleep behaviour disorder and Parkinson's disease: an exploratory study. Brain Imaging and Behavior, 18(6), 1428-1437. https://doi.org/10.1007/s11682-024-00939-x

Terkelsen, M. H., Iranzo, A., Serradell, M., Baun, A. M., Stokholm, M. G., Danielsen, E. H., Østergaard, K., Otto, M., Svendsen, K. B., Møller, M., Johnsen, E. L., Garrido, A., Vilas, D., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Borghammer, P., Tolosa, E. & Pavese, N. (2024). Cholinergic dysfunction in isolated rapid eye movement sleep behaviour disorder links to impending phenoconversion. European Journal of Neurology, 31(12), Article e16503. https://doi.org/10.1111/ene.16503

Kjærgaard, K., Mikkelsen, A. C. D., Landau, A., Eriksen, P. L., Hamilton-Dutoit, S. J., Magnusson, N. E., Thomsen, M., Chen, F., Vilstrup, H. V. A., Mookerjee, R. P., Bay-Richter, C. & Thomsen, K. L. (2024). Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation. JHEP Reports, 6(3), Article 100992. https://doi.org/10.1016/j.jhepr.2023.100992

Leng, F., Hinz, R., Gentleman, S., Dani, M., Brooks, D. J. & Edison, P. (2024). Combined Neuroinflammation and Amyloid PET Markers in Predicting Disease Progression in Cognitively Impaired Subjects. Journal of Alzheimer's Disease, 100(3), 973-986. https://doi.org/10.3233/JAD-230442

Horsager, J., Andersen, K. B., Okkels, N., Knudsen, K., Skjærbæk, C., Van Den Berge, N., Pavese, N., Gottrup, H. & Borghammer, P. (2024). Correlation between dopaminergic and metabolic asymmetry in Lewy body disease - A dual-imaging study. Parkinsonism & Related Disorders, 127, 107117. Article 107117. https://doi.org/10.1016/j.parkreldis.2024.107117

Sigurdsson, H. P., Alcock, L., Firbank, M., Wilson, R., Brown, P., Maxwell, R., Bennett, E., Pavese, N., Brooks, D. J. & Rochester, L. (2024). Developing a novel dual-injection FDG-PET imaging methodology to study the functional neuroanatomy of gait. NeuroImage, 288, Article 120531. https://doi.org/10.1016/j.neuroimage.2024.120531

Bærentzen, S. L., Thomsen, M., Alstrup, A. K. O., Wegener, G., Brooks, D. J., Winterdahl, M. & Landau, A. (2024). Excessive sucrose consumption reduces synaptic density and increases cannabinoid receptors in Göttingen minipigs. Neuropharmacology, 256, Article 110018. https://doi.org/10.1016/j.neuropharm.2024.110018

Pasquini, J., Firbank, M. J., Best, L., Foster, V., Galley, D., Silani, V., Ceravolo, R., Petrides, G., Brooks, D. J., Anderson, K. N. & Pavese, N. (2024). Hypothalamic involvement in multiple system atrophy: A structural MRI study. Journal of the Neurological Sciences, 460, Article 122985. https://doi.org/10.1016/j.jns.2024.122985

Theis, H., Pavese, N., Rektorová, I. & Van Eimeren, T. (2024). Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson's Disease. Journal of Parkinson's Disease, 14(s2), S353-S365. https://doi.org/10.3233/JPD-230385

Staer, K., Iranzo, A., Stokholm, M. G., Hvingelby, V. S., Danielsen, E. H., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Borghammer, P., Tolosa, E. & Pavese, N. (2024). Microglial Activation and Progression of Nigrostriatal Dysfunction in Isolated REM Sleep Behavior Disorder. Movement Disorders, 39(8), 1323-1328. https://doi.org/10.1002/mds.29767

Madsen, L. S., Ismail, R., Parbo, P., Kjeldsen, P. L., Schaldemose, J. L., Hansen, K. V., Gottrup, H., Aanerud, J., Eskildsen, S. F. & Brooks, D. J. (2024). Microglial responses partially mediate the effect of Aβ on cognition in Alzheimer's disease. Alzheimer's & Dementia, 20(11), 8028-8037. https://doi.org/10.1002/alz.14298

Ellis, E. G., Meyer, G. M., Kaasinen, V., Corp, D. T., Pavese, N., Reich, M. M. & Joutsa, J. (2024). Multimodal neuroimaging to characterize symptom-specific networks in movement disorders. npj Parkinson's Disease , 10(1), Article 154. https://doi.org/10.1038/s41531-024-00774-3

Kjeldsen, P. L., Damholdt, M. F., Madsen, L. S., Nissen, P. H., Aanerud, J. F. A., Parbo, P., Ismail, R., Thomsen, M. K., Eskildsen, S. F., Østergaard, L. & Brooks, D. J. (2024). Performance on complex memory tests is associated with β-amyloid in individuals at risk of developing Alzheimer's disease. Journal of Neuropsychology, 18(1), 120-135. Article JNP12332. https://doi.org/10.1111/jnp.12332

Sauerbier, A., Herberg, J., Stopic, V., Loehrer, P. A., Ashkan, K., Rizos, A., Jost, S. T., Schneider, C., Visser-Vandewalle, V., Evans, J., Nimsky, C., Fink, G. R., Antonini, A., Martinez-Martin, P., Silverdale, M., Weintraub, D., Schrag, A., Ray Chaudhuri, K., Timmermann, L. ... EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group (2024). Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease. npj Parkinson's Disease , 10(1), Article 114. https://doi.org/10.1038/s41531-024-00701-6

Staer, K., Iranzo, A., Terkelsen, M. H., Stokholm, M. G., Danielsen, E. H., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Borghammer, P., Tolosa, E. & Pavese, N. (2024). Progression of brain cholinergic dysfunction in patients with isolated rapid eye movement sleep behavior disorder. European Journal of Neurology, 31(1), Article e16101. https://doi.org/10.1111/ene.16101

Arjmand, S., Ilaghi, M., Sisakht, A. K., Guldager, M. B., Wegener, G., Landau, A. M. & Gjedde, A. (2024). Regulation of mitochondrial dysfunction by estrogens and estrogen receptors in Alzheimer's disease: A focused review. Basic & Clinical Pharmacology & Toxicology, 135(2), 115-132. https://doi.org/10.1111/bcpt.14035

Bærentzen, S. L., Thomsen, J. B., Thomsen, M. B., Jakobsen, S., Simonsen, M. T., Wegener, G., Brooks, D. J. & Landau, A. M. (2024). Subanesthetic S-ketamine does not acutely alter striatal dopamine transporter binding in healthy Sprague Dawley female rats. Synapse, 78(4), Article e22294. https://doi.org/10.1002/syn.22294

Hvingelby, V. S. & Pavese, N. (2024). Surgical Advances in Parkinson’s Disease. Current Neuropharmacology, 22(6), 1033-1046. https://doi.org/10.2174/1570159X21666221121094343

Alstrup, A. K. O., Lillethorup, T. P., Landau, A. & Afzelius, P. (2024). The arterial blood sampling associated with PET imaging studies can lead to post-scan complications in Göttingen minipigs. Scandinavian Journal of Laboratory Animal Science, 50(2), 6-12. https://doi.org/10.23675/sjlas.v50i.22397

Galgani, A., Lombardo, F., Frijia, F., Martini, N., Tognoni, G., Pavese, N. & Giorgi, F. S. (2024). The degeneration of locus coeruleus occurring during Alzheimer’s disease clinical progression: a neuroimaging follow-up investigation. Brain Structure & Function, 229(5), 1317-1325. https://doi.org/10.1007/s00429-024-02797-1

Cai, X. L., Pu, C. C., Zhou, S. Z., Wang, Y., Huang, J., Lui, S. S. Y., Moller, A., Cheung, E. F. C., Madsen, K. H., Xue, R., Yu, X. & Chan, R. C. K. (2023). Anterior cingulate glutamate levels associate with functional activation and connectivity during sensory integration in schizophrenia: a multimodal ¹H-MRS and fMRI study. Psychological Medicine, 53(11), 4904-4914. https://doi.org/10.1017/S0033291722001817

Thomsen, M. B., Landau, A. M., Bender, D. & Cumming, P. (2023). Autoradiographic characterization of [¹⁸F]PSMA-1007 binding in rat brain. Synapse, 77(6), Article e22280. https://doi.org/10.1002/syn.22280

Aghakhanyan, G., Galgani, A., Vergallo, A., Lombardo, F., Martini, N., Baldacci, F., Tognoni, G., Leo, A., Guidoccio, F., Siciliano, G., Fornai, F., Pavese, N., Volterrani, D. & Giorgi, F. S. (2023). Brain metabolic correlates of Locus Coeruleus degeneration in Alzheimer's disease: a multimodal neuroimaging study. Neurobiology of Aging, 122, 12-21. https://doi.org/10.1016/j.neurobiolaging.2022.11.002

Madsen, L. S., Parbo, P., Ismail, R., Gottrup, H., Østergaard, L., Brooks, D. J. & Eskildsen, S. F. (2023). Capillary dysfunction correlates with cortical amyloid load in early Alzheimer's disease. Neurobiology of Aging, 123, 1-9. https://doi.org/10.1016/j.neurobiolaging.2022.12.006

Krogsbaek, M., Larsen, N. Y., Landau, A. M., Sanchez, C. & Nyengaard, J. R. (2023). Changes in hypothalamic mu-opioid receptor expression following acute olanzapine treatment in female rats: implications for feeding behavior. Journal of Chemical Neuroanatomy, 132, Article 102324. https://doi.org/10.1016/j.jchemneu.2023.102324

Landau, A., Jakobsen, S., Thomsen, M., Alstrup, A. K. O., Orlowski, D., Jacobsen, J., Wegener, G., Mørk, A., Sørensen, J. C. H. & Doudet, D. J. (2023). Combined In Vivo Microdialysis and PET Studies to Validate [¹¹C]Yohimbine Binding as a Marker of Noradrenaline Release. Biomolecules, 13(4), Article 674. https://doi.org/10.3390/biom13040674

Paoli, D., Mills, R., Brechany, U., Pavese, N. & Nicholson, C. (2023). DBS in tremor with dystonia: VIM, GPi or both? A review of the literature and considerations from a single-center experience. Journal of Neurology, 270(4), 2217-2229. https://doi.org/10.1007/s00415-023-11569-6

Pérez, M., Hoppe, J., Landau, A. M. & Winterdahl, M. (2023). Development and validation of the Male Post-coital Affect Scale for heterosexual men. Acta Neuropsychiatrica, 35(4), 1-6. Article 2300012. https://doi.org/10.1017/neu.2023.12

Galgani, A., Palermo, G., Lombardo, F., Martini, N., Bastiani, L., Vergallo, A., Tommasini, L., Bellini, G., Baldacci, F., Frosini, D., Tognoni, G., Gesi, M., Cademartiri, F., Fornai, F., Pavese, N., Ceravolo, R. & Giorgi, F. S. (2023). Different Patterns of Locus Coeruleus MRI Alteration in Alzheimer’s and Dementia with Lewy Bodies. Current Alzheimer research, 20(4), 277-288. https://doi.org/10.2174/1567205020666230721144603

Khodaii, J., Nomura, Y., Chang, N. H. S., Wong, D. F., Møller, A. & Gjedde, A. (2023). Dopamine D_2/3 Receptor Availabilities in Striatal and Extrastriatal Regions of the Adult Human Brain: Comparison of Four Methods of Analysis. Neurochemical Research, 48(5), 1517-1530. https://doi.org/10.1007/s11064-022-03825-4

Rrapaj, A., Landau, A. M. & Winterdahl, M. (2023). Exploration of possible sex bias in acute social stress research: a semi-systematic review. Acta Neuropsychiatrica, 35(4), 1-29. https://doi.org/10.1017/neu.2023.16

Galgani, A., Lombardo, F., Martini, N., Vergallo, A., Bastiani, L., Hampel, H., Hlavata, H., Baldacci, F., Tognoni, G., De Marchi, D., Ghicopulos, I., De Cori, S., Biagioni, F., Busceti, C. L., Ceravolo, R., Bonuccelli, U., Chiappino, D., Siciliano, G., Fornai, F. ... Giorgi, F. S. (2023). Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia. European Journal of Neurology, 30(1), 32-46. https://doi.org/10.1111/ene.15556

Schmidt, C., Gleesborg, C., Schmidt, H., Kvamme, T. L., Voon, V. & Møller, A. (2023). Neural fingerprints of gambling disorder using diffusion tensor imaging. Psychiatry Research - Neuroimaging, 333, Article 111657. https://doi.org/10.1016/j.pscychresns.2023.111657

Leng, F., Hinz, R., Gentleman, S., Hampshire, A., Dani, M., Brooks, D. J. & Edison, P. (2023). Neuroinflammation is independently associated with brain network dysfunction in Alzheimer's disease. Molecular Psychiatry, 28(3), 1303-1311. https://doi.org/10.1038/s41380-022-01878-z

Paranathala, M. P., Mills, R., Rai, P., Pavese, N., Hussain, M. A., Duddy, M., Nicholson, C. & Jenkins, A. (2023). Patient selection and outcome of deep brain stimulation for multiple sclerosis-associated tremor. British Journal of Neurosurgery. https://doi.org/10.1080/02688697.2023.2277284

Arjmand, S., Bender, D., Jakobsen, S., Wegener, G. & Landau, A. M. (2023). Peering into the Brain's Estrogen Receptors: PET Tracers for Visualization of Nuclear and Extranuclear Estrogen Receptors in Brain Disorders. Biomolecules, 13(9), Article 1405. https://doi.org/10.3390/biom13091405

Kirkeby, A., Nelander, J., Hoban, D. B., Rogelius, N., Bjartmarz, H., Novo Nordisk Cell Therapy R&D, Storm, P., Fiorenzano, A., Adler, A. F., Vale, S., Mudannayake, J., Zhang, Y., Cardoso, T., Mattsson, B., Landau, A. M., Glud, A. N., Sørensen, J. C., Lillethorup, T. P., Lowdell, M. ... Parmar, M. (2023). Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD. Cell Stem Cell, 30(10), 1299-1314.e9. https://doi.org/10.1016/j.stem.2023.08.014

Hvingelby, V., Terkelsen, M. H., Valdemarsen, R. N., Andersen, A. S. M., Danielsen, E. H., Møller, M., Pavese, N. & Johnsen, E. L. (2023). Prevalence and severity of freezing of gait in a Danish cohort of people with Parkinson’s disease. Danish Medical Journal, 70(12), Article A03230209.

Street, D., Jabbari, E., Costantini, A., Jones, P. S., Holland, N., Rittman, T., Jensen, M. T., Chelban, V., Goh, Y. Y., Guo, T., Heslegrave, A. J., Roncaroli, F., Klein, J. C., Ansorge, O., Allinson, K. S. J., Jaunmuktane, Z., Revesz, T., Warner, T. T., Lees, A. J. ... Rowe, J. B. (2023). Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials. Brain, 146(8), 3232-3242. https://doi.org/10.1093/brain/awad105

Real, C. C., Binda, K. H., Thomsen, M. B., Lillethorup, T. P., Brooks, D. J. & Landau, A. M. (2023). Selecting the Best Animal Model of Parkinson's Disease for Your Research Purpose: Insight from in vivo PET Imaging Studies. Current Neuropharmacology, 21(5), 1241 - 1272. https://doi.org/10.2174/1570159X21666230216101659

Arjmand, S., Vadstrup Pedersen, M., Silva, N. R., Landau, A. M., Joca, S. & Wegener, G. (2023). Sex and Estrous Cycle Are Not Mediators of S-Ketamine's Rapid-Antidepressant Behavioral Effects in a Genetic Rat Model of Depression. The international journal of neuropsychopharmacology, 26(5), 350–358. https://doi.org/10.1093/ijnp/pyad016

Krogsbaek, M., Larsen, N. Y., Landau, A. M., Sanchez, C. & Nyengaard, J. R. (2023). Spatial quantification of single cell mRNA and ligand binding of the kappa opioid receptor in the rat hypothalamus. Journal of Chemical Neuroanatomy, 127, Article 102205. https://doi.org/10.1016/j.jchemneu.2022.102205

Andersen, K. B., Hansen, A. K., Schacht, A. C., Horsager, J., Gottrup, H., Klit, H., Danielsen, E. H., Poston, K. L., Pavese, N., Brooks, D. J. & Borghammer, P. (2023). Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [¹¹C]UCB-J and [¹⁸F]FDG PET Study. Movement disorders : official journal of the Movement Disorder Society, 38(5), 796-805. https://doi.org/10.1002/mds.29375

Pasquini, J., Deuschl, G., Pecori, A., Salvadori, S., Ceravolo, R. & Pavese, N. (2023). The Clinical Profile of Tremor in Parkinson's Disease. Movement Disorders Clinical Practice, 10(10), 1496-1506. https://doi.org/10.1002/mdc3.13845

Stewart, C. B., Ledingham, D., Foster, V. K., Anderson, K. N., Sathyanarayana, S., Galley, D., Pavese, N. & Pasquini, J. (2023). The longitudinal progression of autonomic dysfunction in Parkinson's disease: A 7-year study. Frontiers in Neurology, 14, Article 1155669. https://doi.org/10.3389/fneur.2023.1155669

Ray Chaudhuri, K., Leta, V., Bannister, K., Brooks, D. J. & Svenningsson, P. (2023). The noradrenergic subtype of Parkinson disease: from animal models to clinical practice. Nature Reviews Neurology, 19(6), 333-345. https://doi.org/10.1038/s41582-023-00802-5

Henrique Binda, K., Landau, A. M., Chacur, M., Brooks, D. J. & Cristiano Real, C. (2023). Treadmill exercise modulates nigral and hippocampal cannabinoid receptor type 1 in the 6-OHDA model of Parkinson's disease. Brain Research, 1814, Article 148436. https://doi.org/10.1016/j.brainres.2023.148436

Horsager, J., Okkels, N., Fedorova, T. D., Knudsen, K., Skjærbæk, C., Van Den Berge, N., Jacobsen, J., Munk, O. L., Danielsen, E. H., Bender, D., Brooks, D. J. & Borghammer, P. (2022). [ 18F]FEOBV positron emission tomography may not be a suitable method to measure parasympathetic denervation in patients with Parkinson's disease. Parkinsonism & Related Disorders, 104, 21-25. https://doi.org/10.1016/j.parkreldis.2022.09.016

Andersen, O. M., Bøgh, N., Landau, A. M., Pløen, G. G., Jensen, A. M. G., Monti, G., Ulhøi, B. P., Nyengaard, J. R., Jacobsen, K. R., Jørgensen, M. M., Holm, I. E., Kristensen, M. L., Alstrup, A. K. O., Hansen, E. S. S., Teunissen, C. E., Breidenbach, L., Droescher, M., Liu, Y., Pedersen, H. S. ... Sørensen, C. B. (2022). A genetically modified minipig model for Alzheimer's disease with SORL1 haploinsufficiency. Cell Reports Medicine, 3(9), Article 100740. https://doi.org/10.1016/j.xcrm.2022.100740

Kjeldsen, P. L., Parbo, P., Hansen, K. V., Aanerud, J. F. A., Ismail, R., Nissen, P. H., Dalby, R. B., Damholdt, M. F., Borghammer, P. & Brooks, D. J. (2022). Asymmetrical amyloid deposition in preclinical Alzheimer's disease: A PET study. Aging Brain, 2, Article 100048. https://doi.org/10.1016/j.nbas.2022.100048

Galgani, A., Vergallo, A., Campese, N., Lombardo, F., Pavese, N., Petrozzi, L., LoGerfo, A., Franzini, M., Cecchetti, D., Puglisi-Allegra, S., Busceti, C. L., Siciliano, G., Tognoni, G., Baldacci, F., Lista, S., Hampel, H., Fornai, F. & Giorgi, F. S. (2022). Biological determinants of blood-based cytokines in the Alzheimer's disease clinical continuum. Journal of Neurochemistry, 163(1), 40-52. https://doi.org/10.1111/jnc.15686

Madsen, L. S., Nielsen, R. B., Parbo, P., Ismail, R., Mikkelsen, I. K., Gottrup, H., Østergaard, L., Brooks, D. J. & Eskildsen, S. F. (2022). Capillary function progressively deteriorates in prodromal Alzheimer’s disease: A longitudinal MRI perfusion study. Aging Brain, 2, Article 100035. https://doi.org/10.1016/j.nbas.2022.100035

Al-Absi, A.-R., Thambiappa, S. K., Khan, A. R., Glerup, S., Sanchez, C., Landau, A. M. & Nyengaard, J. R. (2022). Df(h22q11)/+ mouse model exhibits reduced binding levels of GABA_A receptors and structural and functional dysregulation in the inhibitory and excitatory networks of hippocampus. Molecular and Cellular Neuroscience, 122, Article 103769. https://doi.org/10.1016/j.mcn.2022.103769

Pasquini, J., Firbank, M. J., Ceravolo, R., Silani, V. & Pavese, N. (2022). Diffusion Magnetic Resonance Imaging Microstructural Abnormalities in Multiple System Atrophy: A Comprehensive Review. Movement Disorders, 37(10), 1963-1984. https://doi.org/10.1002/mds.29195

Landau, A., Van Camp, N. & Petiet, A. (2022). Editorial: Advanced Imaging Techniques and Imaging Markers of Synaptic Density and Brain Connectivity in Animal Models of Neurological Diseases. Frontiers in Neuroscience, 16(98036), Article 980368. https://doi.org/10.3389/fnins.2022.980368

Sigurdsson, H. P., Yarnall, A. J., Galna, B., Lord, S., Alcock, L., Lawson, R. A., Colloby, S. J., Firbank, M. J., Taylor, J.-P., Pavese, N., Brooks, D. J., O'Brien, J. T., Burn, D. J. & Rochester, L. (2022). Gait-Related Metabolic Covariance Networks at Rest in Parkinson's Disease. Movement Disorders, 37(6), 1222-1234. https://doi.org/10.1002/mds.28977

Cury, R. G., Pavese, N., Aziz, T. Z., Krauss, J. K., Moro, E. & the Neuromodulation of Gait Study Group from Movement Disorders Society (2022). Gaps and roadmap of novel neuromodulation targets for treatment of gait in Parkinson’s disease. npj Parkinson's Disease , 8(1), Article 8. https://doi.org/10.1038/s41531-021-00276-6

Andersen, K. B., Hansen, A. K., Knudsen, K., Schacht, A. C., Damholdt, M. F., Brooks, D. J. & Borghammer, P. (2022). Healthy brain aging assessed with [¹⁸F]FDG and [¹¹C]UCB-J PET. Nuclear Medicine and Biology, 112-113, 52-58. https://doi.org/10.1016/j.nucmedbio.2022.06.007

Hvingelby, V. S., Glud, A. N., Sørensen, J. C. H., Tai, Y., Andersen, A. S. M., Johnsen, E., Moro, E. & Pavese, N. (2022). Interventions to improve gait in Parkinson's disease: a systematic review of randomized controlled trials and network meta-analysis. Journal of Neurology, 269(8), 4068–4079 . https://doi.org/10.1007/s00415-022-11091-1

Horsager, J., Okkels, N., Van Den Berge, N., Jacobsen, J., Schact, A., Munk, O. L., Vang, K., Bender, D., Brooks, D. J. & Borghammer, P. (2022). In vivo vesicular acetylcholine transporter density in human peripheral organs: an [ 18F]FEOBV PET/CT study. EJNMMI research, 12(1), Article 17. https://doi.org/10.1186/s13550-022-00889-9

Giorgi, F. S., Martini, N., Lombardo, F., Galgani, A., Bastiani, L., Della Latta, D., Hlavata, H., Busceti, C. L., Biagioni, F., Puglisi-Allegra, S., Pavese, N. & Fornai, F. (2022). Locus Coeruleus magnetic resonance imaging: a comparison between native-space and template-space approach. Journal of Neural Transmission, 129(4), 387-394. https://doi.org/10.1007/s00702-022-02486-5

Giorgi, F. S., Lombardo, F., Galgani, A., Hlavata, H., Della Latta, D., Martini, N., Pavese, N., Ghicopulos, I., Baldacci, F., Coi, A., Scalese, M., Bastiani, L., Keilberg, P., De Marchi, D., Fornai, F. & Bonuccelli, U. (2022). Locus Coeruleus magnetic resonance imaging in cognitively intact elderly subjects. Brain Imaging and Behavior, 16(3), 1077-1087. https://doi.org/10.1007/s11682-021-00562-0

Xu, Z., Anderson, K. N. & Pavese, N. (2022). Longitudinal Studies of Sleep Disturbances in Parkinson’s Disease. Current Neurology and Neuroscience Reports, 22(10), 635-655. https://doi.org/10.1007/s11910-022-01223-5

Horsager, J., Okkels, N., Hansen, A. K., Damholdt, M. F., Andersen, K. H., Fedorova, T. D., Munk, O. L., Danielsen, E. H., Pavese, N., Brooks, D. J. & Borghammer, P. (2022). Mapping Cholinergic Synaptic Loss in Parkinson's Disease: An [18F]FEOBV PET Case-Control Study. Journal of Parkinson's Disease, 12(8), 2493-2506. https://doi.org/10.3233/JPD-223489

Terkelsen, M. H., Hvingelby, V. & Pavese, N. (2022). Molecular Imaging of the GABAergic System in Parkinson’s Disease and Atypical Parkinsonisms. Current Neurology and Neuroscience Reports, 22(12), 867-879. https://doi.org/10.1007/s11910-022-01245-z

Lunde, S. J., Vuust, P., Garza-Villarreal, E. A., Kirsch, I., Møller, A. & Vase, L. (2022). Music-induced analgesia in healthy participants is associated with expected pain levels but not opioid or dopamine-dependent mechanisms. Frontiers in Pain Research, 3, Article 734999. https://doi.org/10.3389/fpain.2022.734999

Terkelsen, M. H., Klæstrup, I. H., Hvingelby, V., Lauritsen, J., Pavese, N. & Romero-Ramos, M. (2022). Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies. Journal of Parkinson's Disease, 12(s1), S149-S163. https://doi.org/10.3233/JPD-223245

Xing, Y., Sapuan, A. H., Martín-Bastida, A., Naidu, S., Tench, C., Evans, J., Sare, G., Schwarz, S. T., Al-bachari, S., Parkes, L. M., Kanavou, S., Raw, J., Silverdale, M., Bajaj, N., Pavese, N., Burn, D., Piccini, P., Grosset, D. G. & Auer, D. P. (2022). Neuromelanin-MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template-Based Standardized Analysis. Movement Disorders, 37(5), 1028-1039. https://doi.org/10.1002/mds.28934

Hvingelby, V., Glud, A., Sørensen, J. C., Tai, Y., Andersen, A. S., Johnsen, E., Moro, E. & Pavese, N. (2022). Neuromodulation for Gait symptoms in PD: Results from a Network Meta-Analysis: Abstracts of the EANS2022. Brain and Spine, 2. https://doi.org/10.1016/j.bas.2022.101594

Pineda-Pardo, J. D. S. A., Sánchez-Ferro, Á., Monje, M. H. G., Pavese, N. & Obeso, J. A. (2022). Onset pattern of nigrostriatal denervation in early Parkinson's disease. Brain, 145(3), 1018-1028. https://doi.org/10.1093/brain/awab378

Chang, N. H. S., Kumakura, Y., Møller, A., Linnet, J., Bender, D., Doudet, D. J., Vafaee, M. S. & Gjedde, A. (2022). On the learning of addictive behavior: Sensation-seeking propensity predicts dopamine turnover in dorsal striatum. Brain Imaging and Behavior, 16(1), 355-365. https://doi.org/10.1007/s11682-021-00509-5

Schofield, C., Chaudhuri, K. R., Carroll, C., Sharma, J. C., Pavese, N., Evans, J., Foltynie, T., Reichmann, H., Zurowska, L., Soares-Da-Silva, P. & Lees, A. (2022). Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's disease. Neurodegenerative Disease Management, 12(2), 77-91. https://doi.org/10.2217/nmt-2021-0057

Dai, W., Zhou, H., Møller, A., Wei, P., Hu, K., Feng, K., Han, J., Li, Q. & Liu, X. (2022). Patients with Methamphetamine Use Disorder Show Highly Utilized Proactive Inhibitory Control and Intact Reactive Inhibitory Control with Long-Term Abstinence. Brain sciences, 12(8), Article 974. https://doi.org/10.3390/brainsci12080974

Jansen, W. J., Janssen, O., Tijms, B. M., Vos, S. J. B., Ossenkoppele, R., Visser, P. J. & Amyloid Biomarker Study Group (2022). Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurology, 79(3), 228-243. https://doi.org/10.1001/jamaneurol.2021.5216

Jiang, R., Chazot, P., Pavese, N., Crookes, D., Bouridane, A. & Celebi, M. E. (2022). Private Facial Prediagnosis as an Edge Service for Parkinson's DBS Treatment Valuation. IEEE Journal of Biomedical and Health Informatics, 26(6), 2703-2713. https://doi.org/10.1109/JBHI.2022.3146369

Steinmüller, J. B., Binda, K. H., Lillethorup, T. P., Søgaard, B., Orlowski, D., Landau, A. M., Bjarkam, C. R., Sørensen, J. C. H. & Glud, A. N. (2022). Quantitative assessment of motor function in minipig models of neurological disorders using a pressure-sensitive gait mat. Journal of Neuroscience Methods, 380, Article 109678. https://doi.org/10.1016/j.jneumeth.2022.109678

O’Brien, J. T., Chouliaras, L., Sultana, J., Taylor, J. P., Ballard, C. & on behalf of the RENEWAL Study Group (2022). RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia—an international Delphi consensus. Alzheimer's Research & Therapy, 14(1), Article 169. https://doi.org/10.1186/s13195-022-01103-7

Zhang, Z., Jiang, R., Zhang, C., Williams, B., Jiang, Z., Li, C. T., Chazot, P., Pavese, N., Bouridane, A. & Beghdadi, A. (2022). Robust Brain Age Estimation Based on sMRI via Nonlinear Age-Adaptive Ensemble Learning. IEEE Transactions on Neural Systems and Rehabilitation Engineering, 30, 2146-2156. https://doi.org/10.1109/TNSRE.2022.3190467

Hvingelby, V. S., Højholt Terkelsen, M., Johnsen, E. L., Møller, M., Danielsen, E. H., Henriksen, T., Glud, A. N., Tai, Y., Møller Andersen, A. S., Meier, K., Borghammer, P., Moro, E., Sørensen, J. C. H. & Pavese, N. (2022). Spinal cord stimulation therapy for patients with Parkinson's disease and gait problems (STEP-PD): study protocol for an exploratory, double-blind, randomised, placebo-controlled feasibility trial. BMJ Neurology Open, 4(2), Article e000333. https://doi.org/10.1136/bmjno-2022-000333

Lillethorup, T. P., Noer, O., Alstrup, A. K. O., Cristiano Real Gregório, C., Stokholm, K., Thomsen, M., Zaer, H., Orlowski, D., Mikkelsen, T. W., Glud, AN., Nielsen, E. H. T., Schacht, A. C., Winterdahl, M., Brooks, D. J., Sørensen, J. C. H. & Landau, A. (2022). Spontaneous partial recovery of striatal dopaminergic uptake despite nigral cell loss in asymptomatic MPTP-lesioned female minipigs. NeuroToxicology, 91, 166-176. https://doi.org/10.1016/j.neuro.2022.05.006

Jesuthasan, A., Garcia, L. R. & Pavese, N. (2022). Studying cognitive function in patients with a long-standing diagnosis of SWEDD. Journal of the Neurological Sciences, 441, Article 120353. https://doi.org/10.1016/j.jns.2022.120353

Rossi, R., Arjmand, S., Bærentzen, S. L., Gjedde, A. & Landau, A. (2022). Synaptic Vesicle Glycoprotein 2A: Features and Functions. Frontiers in Neuroscience, 16, Article 864514. https://doi.org/10.3389/fnins.2022.864514

Arjmand, S., Landau, A. M., Varastehmoradi, B., Andreatini, R., Joca, S. & Wegener, G. (2022). The intersection of astrocytes and the endocannabinoid system in the lateral habenula: on the fast-track to novel rapid-acting antidepressants. Molecular Psychiatry, 27(8), 3138–3149 . https://doi.org/10.1038/s41380-022-01598-4

Arjmand, S., Wegener, G., Landau, A. M. & Eskelund, A. (2022). Tips and traps for behavioural animal experimentation. Acta Neuropsychiatrica, 34(5), 240-252. https://doi.org/10.1017/neu.2022.4

Lang, A. E., Siderowf, A. D., Macklin, E. A., Poewe, W., Brooks, D. J., Fernandez, H. H., Rascol, O., Giladi, N., Stocchi, F., Tanner, C. M., Postuma, R. B., Simon, D. K., Tolosa, E., Mollenhauer, B., Cedarbaum, J. M., Fraser, K., Xiao, J., Evans, K. C., Graham, D. L. ... SPARK Investigators (2022). Trial of Cinpanemab in Early Parkinson's Disease. The New England Journal of Medicine, 387(5), 408-420. https://doi.org/10.1056/NEJMoa2203395

Devos, D., Labreuche, J., Rascol, O., Corvol, J. C., Duhamel, A., Delannoy, P. G., Poewe, W., Compta, Y., Pavese, N., Ruzička, E., Dušek, P., Post, B., Bloem, B. R., Berg, D., Maetzler, W., Otto, M., Habert, M. O., Lehericy, S., Ferreira, J. ... FAIRPARK-II Study Group (2022). Trial of Deferiprone in Parkinson's Disease. New England Journal of Medicine, 387(22), 2045-2055. https://doi.org/10.1056/NEJMoa2209254

the PASADENA Investigators and Prasinezumab Study Group (2022). Trial of Prasinezumab in Early-Stage Parkinson's Disease. New England Journal of Medicine, 387(5), 421-432. https://doi.org/10.1056/NEJMoa2202867

Nielsen, S. V., Dollerup, M. R., Baerentzen, S. L., Landau, A., Munk, O. L. & Alstrup, A. K. O. (2022). Validation and optimization of an automatic blood sampler for preclinical positron emission tomography (PET) research in domestic pigs. Laboratory Animals, 56(3), 287-291. Article 236772211049081. https://doi.org/10.1177/00236772211049081

Venkataraman, A. V., Mansur, A., Rizzo, G., Bishop, C., Lewis, Y., Kocagoncu, E., Lingford-Hughes, A., Huiban, M., Passchier, J., Rowe, J. B., Tsukada, H., Brooks, D. J., Martarello, L., Comley, R. A., Chen, L., Schwarz, A. J., Hargreaves, R., Gunn, R. N., Rabiner, E. A. & Matthews, P. M. (2022). Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer's disease. Science Translational Medicine, 14(658), Article eabk1051. https://doi.org/10.1126/scitranslmed.abk1051

Schmidt, C., Gleesborg, C., Schmidt, H., Kvamme, T. L., Lund, T. E., Voon, V. & Møller, A. (2021). A bias towards natural rewards away from gambling cues in gamblers under‐going active treatment. Brain Research, 1764, Article 147479. https://doi.org/10.1016/j.brainres.2021.147479

Vibholm, A. K., Dietz, M. J., Beniczky, S., Christensen, J., Højlund, A., Jacobsen, J., Bender, D., Møller, A. & Brooks, D. J. (2021). Activated N-methyl-D-aspartate receptor ion channels detected in focal epilepsy with [¹⁸F]GE-179 positron emission tomography. Epilepsia, 62(12), 2899-2908. https://doi.org/10.1111/epi.17074

Knudsen, K., Fedorova, T. D., Horsager, J., Andersen, K. B., Skjærbæk, C., Berg, D., Schaeffer, E., Brooks, D. J., Pavese, N., Van Den Berge, N. & Borghammer, P. (2021). Asymmetric Dopaminergic Dysfunction in Brain-First versus Body-First Parkinson's Disease Subtypes. Journal of Parkinson's Disease, 11(4), 1677-1687. https://doi.org/10.3233/JPD-212761

Pavese, N. (2021). Atypical Parkinsonian Syndromes and Subtypes of Parkinson's Disease. Will a Single Neuroimaging Modality Ever Be Enough? Movement Disorders Clinical Practice, 8(2), 172-174. https://doi.org/10.1002/mdc3.13137

Mullin, S., Stokholm, M. G., Hughes, D., Mehta, A., Parbo, P., Hinz, R., Pavese, N., Brooks, D. J. & Schapira, A. H. (2021). Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease. Movement Disorders, 36(3), 774-779. https://doi.org/10.1002/mds.28375

Lang, A., Siderowf, A., Macklin, E., Poewe, W., Brooks, D., Fernandez, H., Rascol, O., Giladi, N., Stocchi, F., Tanner, C., Postuma, R., Simon, D., Tolosa, E., Mollenhauer, B., Byrne, M., Fraser, K., Xiao, J., Sapir, I., Inra, J. ... Fox, T. (2021). Cinpanemab in Early Parkinson's Disease: Phase 2 SPARK Study Results. Movement Disorders, 36(S1), S180-S181. Article 408. https://doi.org/10.1002/mds.28794

Femminella, G. D., Livingston, N. R., Raza, S., van der Doef, T., Frangou, E., Love, S., Busza, G., Calsolaro, V., Carver, S., Holmes, C., Ritchie, C. W., Lawrence, R. M., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E. ... Edison, P. (2021). Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects? Alzheimer's Research & Therapy, 13(1), Article 47. https://doi.org/10.1186/s13195-021-00784-w

Binda, K. H., Lillethorup, T. P., Real, C. C., Bærentzen, S. L., Nielsen, M. N., Orlowski, D., Brooks, D. J., Chacur, M. & Landau, A. M. (2021). Exercise protects synaptic density in a rat model of Parkinson's disease. Experimental Neurology, 342, 113741. Article 113741. https://doi.org/10.1016/j.expneurol.2021.113741

Brooks, D. J. (2021). Future Imaging in Dementia. Seminars in Nuclear Medicine, 51(3), 303-308. https://doi.org/10.1053/j.semnuclmed.2020.12.001

PSP Genetics Group (2021). Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study. The Lancet Neurology, 20(2), 107-116. https://doi.org/10.1016/S1474-4422(20)30394-X

Brooks, D. J. (2021). Imaging Familial and Sporadic Neurodegenerative Disorders Associated with Parkinsonism. Neurotherapeutics, 18(2), 753-771. https://doi.org/10.1007/s13311-020-00994-4

Eskildsen, S. F., Iranzo, A., Stokholm, M. G., Stær, K., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Borghammer, P., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Tolosa, E., Østergaard, L. & Pavese, N. (2021). Impaired cerebral microcirculation in isolated REM sleep behaviour disorder. Brain : a journal of neurology, 144(5), 1498-1508. https://doi.org/10.1093/brain/awab054

Pagano, G., Molloy, S., Bain, P. G., Rabiner, E. A., Ray Chaudhuri, K., Brooks, D. J. & Pavese, N. (2021). Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: A [¹¹C]-PHNO PET study. Parkinsonism and Related Disorders, 90, 52-56. https://doi.org/10.1016/j.parkreldis.2021.06.025

Thomsen, M., Jacobsen, J., Lillethorup, T. P., Schacht, A. C., Simonsen, M. I. T., Romero-Ramos, M., Brooks, D. J. & Landau, A. (2021). In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET. Journal of Cerebral Blood Flow and Metabolism, 41(4), 819-830. https://doi.org/10.1177/0271678X20931140

Farmen, K., Nissen, S. K., Stokholm, M. G., Iranzo, A., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Borghammer, P., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Tolosa, E., Pavese, N. & Romero-Ramos, M. (2021). Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder. Proceedings of the National Academy of Sciences (PNAS), 118(10), Article e2020858118. https://doi.org/10.1073/pnas.2020858118

Leng, F., Hinz, R., Gentleman, S., Brooks, D. J. & Edison, P. (2021). Neuroinflammation, functional connectivity and structural network integrity in the Alzheimer's spectrum. Alzheimer's & dementia : the journal of the Alzheimer's Association, 17(S3), e055970. https://doi.org/10.1002/alz.055970

Cai, X. L., Wang, Y. M., Wang, Y., Zhou, H. Y., Huang, J., Wang, Y., Lui, S. S. Y., Møller, A., Hung, K. S. Y., Mak, H. K. F., Sham, P. C., Cheung, E. F. C. & Chan, R. C. K. (2021). Neurological Soft Signs Are Associated with Altered Cerebellar-Cerebral Functional Connectivity in Schizophrenia. Schizophrenia Bulletin, 47(5), 1452-1462. https://doi.org/10.1093/schbul/sbaa200

Vibholm, A. K., Landau, A. M., Møller, A., Jacobsen, J., Vang, K., Munk, O. L., Orlowski, D., Sorensen, J. C. H. & Brooks, D. J. (2021). NMDA receptor ion channel activation detected in vivo with [¹⁸F]GE-179 PET after electrical stimulation of rat hippocampus. Journal of Cerebral Blood Flow and Metabolism, 41(6), 1301-1312. https://doi.org/10.1177/0271678X20954928

Jost, S. T., Visser-Vandewalle, V., Rizos, A., Loehrer, P. A., Silverdale, M., Evans, J., Samuel, M., Petry-Schmelzer, J. N., Sauerbier, A., Gronostay, A., Barbe, M. T., Fink, G. R., Ashkan, K., Antonini, A., Martinez-Martin, P., Chaudhuri, K. R., Timmermann, L., Dafsari, H. S. & EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group (2021). Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease. Parkinson's Disease, 7(1), Article 48. https://doi.org/10.1038/s41531-021-00174-x

Thomsen, M. B., Ferreira, S. A., Schacht, A. C., Jacobsen, J., Simonsen, M., Betzer, C., Jensen, P. H., Brooks, D. J., Landau, A. M. & Romero-Ramos, M. (2021). PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats. Neurobiology of Disease, 149, Article 105229. https://doi.org/10.1016/j.nbd.2020.105229

Kinnerup, M. B., Sommerauer, M., Damholdt, M. F., Schaldemose, J. L., Ismail, R., Terkelsen, A. J., Stær, K., Hansen, A., Fedorova, T. D., Knudsen, K., Skjærbæk, C., Borghammer, P., Pavese, N., Brooks, D. J. & Nahimi, A. (2021). Preserved noradrenergic function in Parkinson's disease patients with rest tremor. Neurobiology of Disease, 152, Article 105295. https://doi.org/10.1016/j.nbd.2021.105295

Xu, Z., Anderson, K. N., Saffari, S. E., Lawson, R. A., Chaudhuri, K. R., Brooks, D. & Pavese, N. (2021). Progression of sleep disturbances in Parkinson's disease: a 5-year longitudinal study. Journal of Neurology, 268(1), 312-320. https://doi.org/10.1007/s00415-020-10140-x

Andersen, K. B., Hansen, A. K., Damholdt, M. F., Horsager, J., Skjaerbaek, C., Gottrup, H., Klit, H., Schacht, A. C., Danielsen, E. H., Brooks, D. J. & Borghammer, P. (2021). Reduced Synaptic Density in Patients with Lewy Body Dementia: An [¹¹C-]UCB-J PET Imaging Study. Movement Disorders, 36(9), 2057-2065. https://doi.org/10.1002/mds.28617

Doppler, C. E. J., Kinnerup, M. B., Brune, C., Farrher, E., Betts, M., Fedorova, T. D., Schaldemose, J. L., Knudsen, K., Ismail, R., Seger, A. D., Hansen, A. K., Stær, K., Fink, G. R., Brooks, D. J., Nahimi, A., Borghammer, P. & Sommerauer, M. (2021). Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease. Brain : a journal of neurology, 144(9), 2732–2744. https://doi.org/10.1093/brain/awab236

Pasquini, J. & Pavese, N. (2021). Striatal dopaminergic denervation and hypomimia in Parkinson's disease. European Journal of Neurology, 28(1), e2-e3. https://doi.org/10.1111/ene.14483

Kuebler, L., Buss, S., Leonov, A., Ryazanov, S., Schmidt, F., Maurer, A., Weckbecker, D., Landau, A. M., Lillethorup, T. P., Bleher, D., Saw, R. S., Pichler, B. J., Griesinger, C., Giese, A. & Herfert, K. (2021). [¹¹C]MODAG-001-towards a PET tracer targeting α-synuclein aggregates. European Journal of Nuclear Medicine and Molecular Imaging, 48(6), 1759–1772 . https://doi.org/10.1007/s00259-020-05133-x

Pasquini, J., Brooks, D. J. & Pavese, N. (2021). The Cholinergic Brain in Parkinson's Disease. Movement Disorders Clinical Practice, 8(7), 1012-1026. https://doi.org/10.1002/mdc3.13319

Stokholm, K., Thomsen, M. B., Phan, J. A., Møller, L. K., Bay-Richter, C., Christiansen, S. H., Woldbye, D. P. D., Romero-Ramos, M. & Landau, A. M. (2021). α-Synuclein Overexpression Increases Dopamine D2/3 Receptor Binding and Immune Activation in a Model of Early Parkinson’s Disease. Biomedicines, 9(12), Article 1876. https://doi.org/10.3390/biomedicines9121876

Nicholas, R., Brooks, D. & Owen, D. (2020). 18F-GE180, a radioligand for the TSPO protein: not ready for clinical trials in multiple sclerosis. European journal of nuclear medicine and molecular imaging, 47(10), 2242-2243. https://doi.org/10.1007/s00259-020-04844-5

Vibholm, A. K., Landau, A., Alstrup, A. K. O., Jacobsen, J., Hansen, K. V., Munk, O. L., Dietz, M., Orlowski, D., Sorensen, J. C. & Brooks, D. J. (2020). Activation of NMDA receptor ion channels by deep brain stimulation in the pig visualised with [18F]GE-179 PET. Brain Stimulation, 13(4), 1071-1078. https://doi.org/10.1016/j.brs.2020.03.019

Huo, W., Angeles, P., Tai, Y. F., Pavese, N., Wilson, S., Hu, M. T. & Vaidyanathan, R. (2020). A Heterogeneous Sensing Suite for Multisymptom Quantification of Parkinson's Disease. I E E E Transactions on Neural Systems and Rehabilitation Engineering, 28(6), 1397-1406. Article 9064818. https://doi.org/10.1109/TNSRE.2020.2978197

Andersen, K. B., Hansen, A. K., Sommerauer, M., Fedorova, T. D., Knudsen, K., Vang, K., Van Den Berge, N., Kinnerup, M., Nahimi, A., Pavese, N., Brooks, D. J. & Borghammer, P. (2020). Altered sensorimotor cortex noradrenergic function in idiopathic REM sleep behaviour disorder: A PET study. Parkinsonism & Related Disorders, 75, 63-69. https://doi.org/10.1016/j.parkreldis.2020.05.013

Chételat, G., Arbizu, J., Barthel, H., Garibotto, V., Law, I., Morbelli, S., van de Giessen, E., Agosta, F., Barkhof, F., Brooks, D. J., Carrillo, M. C., Dubois, B., Fjell, A. M., Frisoni, G. B., Hansson, O., Herholz, K., Hutton, B. F., Jack, C. R., Lammertsma, A. A. ... Drzezga, A. (2020). Amyloid-PET and ¹⁸F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. Lancet Neurology, 19(11), 951-962. https://doi.org/10.1016/S1474-4422(20)30314-8

Fox, T., Siderowf, A. D., Fernandez, H. H., Tanner, C. M., Postuma, R. B., Simon, D. K., Byrne, M., Lang, A. E., Brooks, D., Rascol, O., Tolosa, E., Poewe, W., Stocchi, F., Mollenhauer, B., Giladi, N., Hirschhorn, B., Cedarbaum, J. M., Nomikos, G., Fanning, L. ... Brys, M. (2020). Baseline Characteristics of Participants of the SPARK Trial, a Phase 2 Study of the anti-alpha-synuclein antibody Cinpanemab (BIIB054) in Parkinson's Disease (1579). Neurology, 94(15).

Stær, K., Iranzo, A., Stokholm, M., Ostergaard, K., Serradell, M., Otto, M., Svendsen, K., Pla, A., Vilas, D., Santamaria, J., Moller, A., Gaig, C., Brooks, D., Borghammer, P., Tolosa, E. & Pavese, N. (2020). Brain cholinergic dysfunction in patients with isolated REM sleep behavior disorder: A clinical and 11C-Donepezil PET follow-up study. Movement Disorders, 35(S1), S283-S283. https://onlinelibrary.wiley.com/toc/15318257/2020/35/S1

Horsager, J., Andersen, K. B., Knudsen, K., Skjærbæk, C., Fedorova, T. D., Okkels, N., Schaeffer, E., Bonkat, S. K., Geday, J., Otto, M., Sommerauer, M., Danielsen, E. H., Bech, E., Kraft, J., Munk, O. L., Hansen, S. D., Pavese, N., Göder, R., Brooks, D. J. ... Borghammer, P. (2020). Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study. Brain, 143(10), 3077-3088. https://doi.org/10.1093/brain/awaa238

Mansur, A., Rabiner, E. A., Comley, R. A., Lewis, Y., Middleton, L. T., Huiban, M., Passchier, J., Tsukada, H., Gunn, R. N. & MIND-MAPS Consortium (2020). Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: ¹⁸F-BCPP-EF, ¹¹C-SA-4503, and ¹¹C-UCB-J C-SA-4503, and 11C-UCB-JC-SA-4503, and 11C-UCB-J1. Journal of Nuclear Medicine, 61(1), 96-103. https://doi.org/10.2967/jnumed.119.228080

Gersel Stokholm, M., Iranzo, A., Østergaard, K., Serradell, M., Otto, M., Bacher Svendsen, K., Garrido, A., Vilas, D., Fedorova, T. D., Santamaria, J., Møller, A., Gaig, C., Hiraoka, K., Brooks, D. J., Okamura, N., Borghammer, P., Tolosa, E. & Pavese, N. (2020). Cholinergic denervation in patients with idiopathic rapid eye movement sleep behaviour disorder. European Journal of Neurology, 27(4), 644-652. https://doi.org/10.1111/ene.14127

Bellini, G., Best, L. A., Brechany, U., Mills, R. & Pavese, N. (2020). Clinical Impact of Deep Brain Stimulation on the Autonomic System in Patients with Parkinson's Disease. Movement Disorders Clinical Practice, 7(4), 373-382. https://doi.org/10.1002/mdc3.12938

Femminella, G. D., Frangou, E., Love, S. B., Busza, G., Holmes, C., Ritchie, C., Lawrence, R., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E., Underwood, B. R., Prasanna, A., Koranteng, P., Karim, S., Junaid, K. ... Edison, P. (2020). Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study). Trials, 21, Article 660. https://doi.org/10.1186/s13063-020-04608-4

Stær, K., Iranzo, A., Stokholm, M. G., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Borghammer, P., Tolosa, E. & Pavese, N. (2020). Cortical cholinergic dysfunction correlates with microglial activation in the substantia innominata in REM sleep behavior disorder. Parkinsonism & Related Disorders, 81, 89-93. https://doi.org/10.1016/j.parkreldis.2020.10.014

Jabbari, E., Holland, N., Chelban, V., Jones, P. S., Lamb, R., Rawlinson, C., Guo, T., Costantini, A. A., Tan, M. M. X., Heslegrave, A. J., Roncaroli, F., Klein, J. C., Ansorge, O., Allinson, K. S. J., Jaunmuktane, Z., Holton, J. L., Revesz, T., Warner, T. T., Lees, A. J. ... Morris, H. R. (2020). Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome. JAMA Neurology, 77(3), 377-387. https://doi.org/10.1001/jamaneurol.2019.4347

Palermo, G., Giannoni, S., Frosini, D., Morganti, R., Volterrani, D., Bonuccelli, U., Pavese, N. & Ceravolo, R. (2020). Dopamine Transporter, Age, and Motor Complications in Parkinson's Disease: A Clinical and Single-Photon Emission Computed Tomography Study. Movement Disorders, 35(6), 1028-1036. https://doi.org/10.1002/mds.28008

Morbelli, S., Esposito, G., Arbizu, J., Barthel, H., Boellaard, R., Bohnen, N., Brooks, D. J., Darcourt, J., Dickson, J. C., Douglas, D., Drzezga, A., Dubroff, J., Ekmekcioglu, O., Garibotto, V., Herscovitch, P., Kuo, P., Lammertsma, A., Pappata, S., Penuelas, I. ... Law, I. (2020). EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0. European Journal of Nuclear Medicine and Molecular Imaging, 47(8), 1885-1912. https://doi.org/10.1007/s00259-020-04817-8

Cai, X. L., Xie, D. J., Madsen, K. H., Wang, Y. M., Bögemann, S. A., Cheung, E. F. C., Møller, A. & Chan, R. C. K. (2020). Generalizability of machine learning for classification of schizophrenia based on resting-state functional MRI data. Human Brain Mapping, 41(1), 172-184. https://doi.org/10.1002/hbm.24797

Sigurdsson, H., Yarnall, A., Galna, B., Lord, S., Alcock, L., Morris, R., Lawson, R., Colloby, S., Firbank, M., Pavese, N., Brooks, D., O'brien, J., Burn, D. & Rochester, L. (2020). Identifying neural signatures of Parkinson's disease that predict decline in gait and postural control. Movement Disorders, 35(Suppl. S1), S281-S282. https://doi.org/10.1002/mds.28268

Wang, Y. M., Yang, Z. Y., Cai, X. L., Zhou, H. Y., Zhang, R. T., Yang, H. X., Liang, Y. S., Zhu, X. Z., Madsen, K. H., Sørensen, T. A., Møller, A., Wang, Z., Cheung, E. F. C. & Chan, R. C. K. (2020). Identifying Schizo-Obsessive Comorbidity by Tract-Based Spatial Statistics and Probabilistic Tractography. Schizophrenia Bulletin, 46(2), 442-453. https://doi.org/10.1093/schbul/sbz073

Stokholm, M. G., Garrido, A., Tolosa, E., Serradell, M., Iranzo, A., Ostergaard, K., Borghammer, P., Moller, A., Parbo, P., Staer, K., Brooks, D. J., Jose Marti, M. & Pavese, N. (2020). Imaging dopamine function and microglia in asymptomatic LRRK2 mutation carriers. Journal of Neurology, 267(8), 2296-2300. https://doi.org/10.1007/s00415-020-09830-3

Nielsen, R. B., Parbo, P., Ismail, R., Dalby, R., Tietze, A., Brændgaard, H., Gottrup, H., Brooks, D. J., Østergaard, L. & Eskildsen, S. F. (2020). Impaired perfusion and capillary dysfunction in prodromal Alzheimer's disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 12(1), Article e12032. https://doi.org/10.1002/dad2.12032

Pagano, G., Molloy, S., Bain, P., Rabiner, E., Chaudhuri, K., Brooks, D. & Pavese, N. (2020). Impulse control disorder and ventral striatum dopamine D3 receptor availability in Parkinson's disease. Movement Disorders, 35, S261-S261. https://doi.org/10.1002/mds.28268

Nicholas, R., Brooks, D. & Owen, D. (2020). In Response to Letter from Fregonara et al. 2019. Molecular Imaging and Biology, 22(1), 13-14. https://doi.org/10.1007/s11307-019-01463-x

Pagano, G., Molloy, S., Bain, P., Rabiner, E., Chaudhuri, K., Brooks, D. & Pavese, N. (2020). Levodopa-induced dyskinesias and substantia nigra dopamine D3 receptor availability in Parkinson's disease. Movement Disorders, 35, S261-S261. https://doi.org/10.1002/mds.28268

Giorgi, F. S., Biagioni, F., Galgani, A., Pavese, N., Lazzeri, G. & Fornai, F. (2020). Locus coeruleus modulates neuroinflammation in parkinsonism and dementia. International Journal of Molecular Sciences , 21(22), 1-21. Article 8630. https://doi.org/10.3390/ijms21228630

Parbo, P., Madsen, L. S., Ismail, R., Zetterberg, H., Blennow, K., Eskildsen, S. F., Vorup-Jensen, T. & Brooks, D. J. (2020). Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer's disease. Alzheimer's Research & Therapy, 12(1), Article 3. https://doi.org/10.1186/s13195-019-0574-0

Staer, K., Iranzo, A., Stokholm, M., Ostergaard, K., Serradell, M., Otto, M., Svendsen, K., Pla, A., Vilas, D., Santamaria, J., Moller, A., Gaig, C., Brooks, D., Borghammer, P., Tolosa, E. & Pavese, N. (2020). Microglial activation associated with a faster progression of nigrostriatal dysfunction in patients with isolated REM sleep behavior disorder. Movement Disorders, 35(Suppl. S1), S283-S283. https://doi.org/10.1002/mds.28268

Miani, A., Di Bernardo, G. A., Højgaard, A. D., Earp, B. D., Zak, P. J., Landau, A. M., Hoppe, J. & Winterdahl, M. (2020). Neonatal male circumcision is associated with altered adult socio-affective processing. Heliyon, 6(11), Article e05566. https://doi.org/10.1016/j.heliyon.2020.e05566

Kinnerup, M., Doppler, C., Farrher, E., Fedorova, T., Schaldemose, J., Knudsen, K., Isamail, R., Hansen, A., Staer, K., Fink, G., Shah, J., Brooks, D., Nahimi, A., Borghammer, P. & Sommerauer, M. (2020). Noradrenergic terminal and locus coeruleus cell loss may be uncoupled in Parkinson's disease - a PET and MRI multi-modal imaging study. Movement Disorders, 35(Suppl. S1), S251. https://doi.org/10.1002/mds.28268

Thomsen, M. B., Schacht, A. C., Alstrup, A. K. O., Jacobsen, J., Lillethorup, T. P., Bærentzen, S. L., Noer, O., Orlowski, D., Elfving, B., Müller, H. K., Brooks, D. J. & Landau, A. M. (2020). Preclinical PET Studies of [¹¹C]UCB-J Binding in Minipig Brain. Molecular Imaging and Biology, 22(5), 1290-1300. https://doi.org/10.1007/s11307-020-01506-8

Pasquini, J., Ceravolo, R., Brooks, D. J., Bonuccelli, U. & Pavese, N. (2020). Progressive loss of raphe nuclei serotonin transporter in early Parkinson's disease: A longitudinal ¹²³I-FP-CIT SPECT study. Parkinsonism & Related Disorders, 77, 170-175. https://doi.org/10.1016/j.parkreldis.2019.03.025

Hansen, A. K., Parbo, P., Ismail, R., Østergaard, K., Brooks, D. J. & Borghammer, P. (2020). Tau Tangles in Parkinson's Disease: A 2-Year Follow-Up Flortaucipir PET Study. Journal of Parkinson's Disease, 10(1), 161-171. https://doi.org/10.3233/JPD-191774

Ismail, R., Parbo, P., Madsen, L. S., Hansen, A. K., Hansen, K. V., Schaldemose, J. L., Kjeldsen, P. L., Stokholm, M. G., Gottrup, H., Eskildsen, S. F. & Brooks, D. J. (2020). The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer's disease: a longitudinal PET study. Journal of Neuroinflammation, 17(1), Article 151. https://doi.org/10.1186/s12974-020-01820-6

Schmidt, C., Skandali, N., Gleesborg, C., Kvamme, T. L., Schmidt, H., Frisch, K., Møller, A. & Voon, V. (2020). The role of dopaminergic and serotonergic transmission in the processing of primary and monetary reward. Neuropsychopharmacology, 45(9), 1490-1497. https://doi.org/10.1038/s41386-020-0702-3

Pavese, N., Tai, Y. F., Yousif, N., Nandi, D. & Bain, P. G. (2020). Traditional Trial and Error versus Neuroanatomic 3-Dimensional Image Software-Assisted Deep Brain Stimulation Programming in Patients with Parkinson Disease. World Neurosurgery, 134, e98-e102. https://doi.org/10.1016/j.wneu.2019.09.106

Landau, A. M., Noer, O., Alstrup, A. K. O., Audrain, H., Wegener, G., Gjedde, A., Doudet, D. J. & Winterdahl, M. (2020). Type of Anaesthetic Influences [11C]MDL100,907 Binding to 5HT2A Receptors in Porcine Brain. Molecular Imaging and Biology, 22(4), 797-804. https://doi.org/10.1007/s11307-020-01476-x

Ismail, R., Parbo, P., Hansen, K. V., Schaldemose, J. L., Dalby, R. B., Tietze, A., Kjeldsen, P. L., la Cour, S. H., Qvist, P., Gottrup, H., Eskildsen, S. F. & Brooks, D. J. (2019). Abnormal Amyloid Load in Mild Cognitive Impairment: The Effect of Reducing the PiB-PET Threshold. Journal of Neuroimaging, 29(4), 499-505. https://doi.org/10.1111/jon.12629

Metaxas, A., Thygesen, C., Kempf, S. J., Anzalone, M., Vaitheeswaran, R., Petersen, S., Landau, A. M., Audrain, H., Teeling, J. L., Darvesh, S., Brooks, D. J., Larsen, M. R. & Finsen, B. (2019). Ageing and amyloidosis underlie the molecular and pathological alterations of tau in a mouse model of familial Alzheimer's disease. Scientific Reports, 9(1), Article 15758. https://doi.org/10.1038/s41598-019-52357-5

Wang, Y., Zou, L., Xie, W., Yang, Z., Zhu, X., Cheung, EFC., Sørensen, T. A., Møller, A. & Chan, R. C. K. (2019). Altered functional connectivity of the default mode network in patients with schizo-obsessive comorbidity: A comparison between schizophrenia and obsessive-compulsive disorder. Schizophrenia Bulletin, 45(1), 199-210. https://doi.org/10.1093/schbul/sbx194

Perani, D., Iaccarino, L., Lammertsma, A. A., Windhorst, A. D., Edison, P., Boellaard, R., Hansson, O., Nordberg, A., Jacobs, A. H. & Partners IMBI Project (2019). A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies. Alzheimer's & Dementia, 15(8), 1081-1103. https://doi.org/10.1016/j.jalz.2019.02.004

IMBI Brain Imaging Working Group (2019). Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 11, 327-332. https://doi.org/10.1016/j.dadm.2019.02.004

Møller, A., Rømer Thomsen, K., Brooks, D. J., Mouridsen, K., Blicher, J. U., Hansen, K. V. & Lou, H. C. (2019). Attenuation of dopamine-induced GABA release in problem gamblers. Brain and Behavior, 9(3), Article e01239. https://doi.org/10.1002/brb3.1239

Horsager, J., Knudsen, K., Andersen, K., Skjaerbaek, C., Fedorova, T., Geday, J., Kraft, J., Bech, E., Danielsen, E., Moller, M., Pavese, N., Brooks, D. & Borghammer, P. (2019). "Brain-first" vs. "body-first" Parkinson's disease is determined by RBD-status - a multi-modality imaging study. Movement Disorders, 34(S2), S796-S796. https://www.mdsabstracts.org/abstract/brain-first-vs-body-first-parkinsons-disease-is-determined-by-rbd-status-a-multi-modality-imaging-study/

Pasquini, J., Durcan, R., Wiblin, L., Gersel Stokholm, M., Rochester, L., Brooks, D. J., Burn, D. & Pavese, N. (2019). Clinical implications of early caudate dysfunction in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 90(10), 1098-1104. https://doi.org/10.1136/jnnp-2018-320157

McGinnity, C. J., Årstad, E., Beck, K., Brooks, D. J., Coles, J. P., Duncan, J. S., Galovic, M., Hinz, R., Hirani, E., Howes, O. D., Jones, P. A., Koepp, M. J., Luo, F., Riaño Barros, D. A., Singh, N., Trigg, W. & Hammers, A. (2019). Comment on " In Vivo [18F]GE-179 Brain Signal Does Not Show NMDA-Specific Modulation with Drug Challenges in Rodents and Nonhuman Primates". ACS Chemical Neuroscience, 10(1), 768-772. https://doi.org/10.1021/acschemneuro.8b00246

Sridharan, S., Raffel, J., Nandoskar, A., Record, C., Brooks, D., Owen, D., Sharp, D., Muraro, P., Gunn, R. & Nicholas, R. (2019). Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [ ¹⁸F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter. Multiple Sclerosis Journal, 21(5), 935-944. https://doi.org/10.1007/s11307-019-01323-8

Hvilsom, A. S. T., Lillethorup, T. P., Iversen, P., Doudet, D. J., Wegener, G. & Landau, A. M. (2019). Cortical and striatal serotonin transporter binding in a genetic rat model of depression and in response to electroconvulsive stimuli. European Neuropsychopharmacology, 29(4), 493-500. https://doi.org/10.1016/j.euroneuro.2019.02.009

Fernandes, H. M., Cabral, J., van Hartevelt, T. J., Lord, L. D., Gleesborg, C., Møller, A., Deco, G., Whybrow, P. C., Petrovic, P., James, A. C. & Kringelbach, M. L. (2019). Disrupted brain structural connectivity in Pediatric Bipolar Disorder with psychosis. Scientific Reports, 9(1), Article 13638. https://doi.org/10.1038/s41598-019-50093-4

Álvarez-Martos, I., Møller, A. & Ferapontova, E. E. (2019). Dopamine Binding and Analysis in Undiluted Human Serum and Blood by the RNA-Aptamer Electrode. ACS Chemical Neuroscience, 10(3), 1706-1715. https://doi.org/10.1021/acschemneuro.8b00616

Schubert, J. J., Veronese, M., Marchitelli, L., Bodini, B., Tonietto, M., Stankoff, B., Brooks, D. J., Bertoldo, A., Edison, P. & Turkheimer, F. E. (2019). Dynamic ¹¹C-PIB PET shows cerebrospinal fluid flow alterations in Alzheimer disease and multiple sclerosis. Journal of Nuclear Medicine, 60(10), 1452-1460. https://doi.org/10.2967/jnumed.118.223834

Landau, A., Alstrup, A. K. O., Noer, O., Winterdahl, M., Audrain, H., Møller, A., Videbech, P., Wegener, G., Gjedde, A. & Doudet, D. J. (2019). Electroconvulsive stimulation differentially affects [¹¹C]MDL100,907 binding to cortical and subcortical 5HT_2A receptors in porcine brain. Journal of Psychopharmacology, 33(6), 714-721. Article 269881119836212. https://doi.org/10.1177/0269881119836212

Femminella, G. D., Frangou, E., Love, S. B., Busza, G., Holmes, C., Ritchie, C., Lawrence, R., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E., Underwood, B. R., Prasanna, A., Koranteng, P., Karim, S., Junaid, K. ... Edison, P. (2019). Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study). Trials, 20(1), Article 191. https://doi.org/10.1186/s13063-019-3259-x

Venkataraman, A. V., Mansur, A., Huiban, M., Passchier, J., Rowe, J. B., Tsukada, H., Brooks, D., Gunn, R. N., Matthews, P. M., Rabiner, E. A. & MINDMAPS Consortium (2019). Evaluation of mitochondrial and synaptic function in Alzheimer's disease (AD): a [F-18]BCPP-EF, [C-11]SA4503 and [C-11]UCB-J PET study. Journal of Cerebral Blood Flow and Metabolism, 39(Suppl. 1), 121-122.

Nielsen, R. B., Parbo, P., Ismail, R., Dalby, R., Tietze, A., Braendgaard, H., Gottrup, H., Brooks, D. J., Ostergaard, L. & Eskildsen, S. F. (2019). Impaired perfusion and capillary distribution of blood in mild cognitive impairment: Relation to oxygenation and amyloid load. Journal of Cerebral Blood Flow and Metabolism, 39(1, suppl.), 147. Article PA00-A28. https://doi.org/10.1177/0271678X19851017

Metaxas, A., Thygesen, C., Briting, S. R. R., Landau, A., Darvesh, S. & Finsen, B. (2019). Increased Inflammation and Unchanged Density of Synaptic Vesicle Glycoprotein 2A (SV2A) in the Postmortem Frontal Cortex of Alzheimer’s Disease Patients. Frontiers in Cellular Neuroscience, 13, Article 538. https://doi.org/10.3389/fncel.2019.00538

Pavese, N. (2019). Is neuromelanin the imaging biomarker for the early diagnosis of Parkinson's disease that we were looking for? Parkinsonism and Related Disorders, 58, 1-2. https://doi.org/10.1016/j.parkreldis.2018.12.013

Mollenhauer, B., Caspell-Garcia, C. J., Coffey, C. S., Taylor, P., Singleton, A., Shaw, L. M., Trojanowski, J. Q., Frasier, M., Simuni, T., Iranzo, A., Oertel, W., Siderowf, A., Weintraub, D., Seibyl, J., Toga, A. W., Tanner, C. M., Kieburtz, K., Chahine, L. M., Marek, K. ... PPMI Study (2019). Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease. Movement Disorders, 34(9), 1354-1364. https://doi.org/10.1002/mds.27806

Femminella, G. D., Dani, M., Wood, M., Fan, Z., Calsolaro, V., Atkinson, R., Edginton, T., Hinz, R., Brooks, D. J. & Edison, P. (2019). Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume. Neurology, 92(12), E1331-E1343. https://doi.org/10.1212/WNL.0000000000007133